{"id":"attenuated-alive-hav-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This immune response helps the body develop antibodies to fight the virus, providing long-term protection against hepatitis A infection. The vaccine is made from inactivated hepatitis A virus, which is grown in cell cultures and then inactivated with chemicals or heat. This process makes the virus unable to cause disease but still stimulates an immune response.","oneSentence":"Attenuated alive HAV vaccine works by exposing the body to a weakened form of the hepatitis A virus, prompting an immune response without causing the disease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:29:33.685Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis A"}]},"trialDetails":[{"nctId":"NCT02002065","phase":"","title":"The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2008-10","conditions":"Hepatitis A","enrollment":332}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Attenuated alive HAV vaccine","genericName":"Attenuated alive HAV vaccine","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Attenuated alive HAV vaccine works by exposing the body to a weakened form of the hepatitis A virus, prompting an immune response without causing the disease. Used for Prevention of hepatitis A.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}